Article taken from Milano Corriere, by Eleonora Lanzetti.
"Diasorin would have been" favored to the detriment of other potential competitors by transferring to it all the results of research and experimentation carried out by the Irccs San Matteo Foundation of Pavia, in the field of serological tests for the diagnosis of Covid-19 infection ". This is the hypothesis that the investigators coordinated by the Pavia Assistant Prosecutor, Mario Venditti and Dr. Paolo Mazza, are following the agreement between the Policlinico di Pavia and Diasorin on serological tests. The financiers at dawn this morning carried out various home and local searches against - reads a note - "of different subjects investigated for disturbed freedom of the procedure of choice of the contractor and peculiar." Among the subjects investigated are the top management of the IRCCS San Matteo Foundation: President of San Matteo, Alessandro Venturi, the General Manager, Carlo Nicora, and the Scientific Director of the Irccs San Matteo di Pavia Foundation, the R responsible of the Molecular Virology Laboratory, prof. Fausto Baldanti, as well as the CEO of the Piedmontese biotechnology company Diasorin Spa. "